|
OSTC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.626600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.738600E-03 |
| Normal-vs-Stage2 |
8.760300E-02 |
| Normal-vs-Stage3 |
4.40170000000073E-05 |
| Normal-vs-Stage4 |
3.23380000000206E-07 |
| Stage1-vs-Stage2 |
8.863200E-01 |
| Stage1-vs-Stage3 |
4.002100E-02 |
| Stage1-vs-Stage4 |
6.413900E-04 |
| Stage2-vs-Stage3 |
2.848200E-01 |
| Stage2-vs-Stage4 |
4.304100E-02 |
| Stage3-vs-Stage4 |
1.686570E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.26469999999868E-05 |
| Normal-vs-AfricanAmerican |
2.291900E-02 |
| Normal-vs-Asian |
1.020120E-04 |
| Caucasian-vs-AfricanAmerican |
7.693600E-01 |
| Caucasian-vs-Asian |
6.225200E-01 |
| AfricanAmerican-vs-Asian |
9.815400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.385270E-04 |
| Normal-vs-Female |
6.414000E-04 |
| Male-vs-Female |
3.204600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.878900E-03 |
| Normal-vs-Age(41-60Yrs) |
4.43279999999824E-05 |
| Normal-vs-Age(61-80Yrs) |
3.595100E-04 |
| Normal-vs-Age(81-100Yrs) |
7.670400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.201390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.703960E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.567990E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.376000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.321900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.369800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.986100E-02 |
| Classical-VS-Follicular |
1.163400E-03 |
| Classical-VS-Other |
6.314200E-01 |
| Classical-VS-Normal |
1.50923999999719E-05 |
| Tall-VS-Follicular |
2.632900E-04 |
| Tall-VS-Other |
7.418400E-01 |
| Tall-VS-Normal |
1.60264999999882E-05 |
| Follicular-VS-Other |
1.873240E-01 |
| Follicular-VS-Normal |
9.634200E-01 |
| Other-VS-Normal |
1.439410E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.688100E-02 |
| Normal-vs-N1 |
9.71439999997159E-07 |
| N0-vs-N1 |
8.369400E-04 |
|
|
